Brief: Alzinova Submits Request For Pre-IND Meeting With FDA, Applies For EMA Scientific Advice

Alzinova AB

13/06/2023 07:21

June 13 (Reuters) - Alzinova AB  ALZ.ST :
    * ALZINOVA SUBMITS REQUEST FOR PRE-IND MEETING WITH FDA AND
APPLIES FOR EMA SCIENTIFIC ADVICE
    * PURPOSE OF REGULATORY INTERACTIONS IS TO PREPARE FOR CO'S
PHASE
2 STUDY WITH ALZ-101 VACCINE CANDIDATE BEING DEVELOPED FOR
TREATMENT OF ALZHEIMER'S DISEASE

Source text for Eikon:  ID:nMFN68lbpk 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))